Welcome to our dedicated page for Cadre Hldgs SEC filings (Ticker: CDRE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Cadre Holdings, Inc. (NYSE: CDRE) SEC filings page on Stock Titan provides access to the company’s official disclosures filed with the U.S. Securities and Exchange Commission. As a Delaware corporation listed on the New York Stock Exchange under the symbol CDRE, Cadre submits current reports on Form 8‑K, annual and quarterly reports, and other documents that describe its operations in safety and survivability equipment for law enforcement, first responder, military and nuclear markets.
In its Form 8‑K filings, Cadre reports material events such as quarterly financial results, investor presentations and significant transactions. For example, the company has filed 8‑Ks to furnish earnings press releases and slide presentations, and to disclose a securities purchase agreement to acquire TYR Tactical, a manufacturer of tactical gear and equipment for military, law enforcement and government agencies worldwide. These filings also confirm details such as Cadre’s incorporation in Delaware and its CDRE listing on the New York Stock Exchange.
Through its SEC reports, Cadre discusses non‑GAAP financial measures including EBITDA, adjusted EBITDA and adjusted EBITDA margin, explaining how these metrics relate to its GAAP results. Filings may also describe contract awards, like blast exposure monitoring programs handled by its Med‑Eng subsidiary, and provide additional context on acquisitions in nuclear safety and tactical equipment.
On Stock Titan, investors can review Cadre’s SEC filings alongside AI‑powered summaries that clarify key points in lengthy documents. Real‑time updates from EDGAR help users track new 8‑Ks, 10‑Qs and 10‑Ks as they are filed, while insider and governance‑related disclosures can be used to analyze management decisions and capital allocation. This page is a resource for understanding how Cadre communicates its financial performance, strategic transactions and risk factors through its regulatory filings.
Cadre Holdings (CDRE) filed a Form 4 showing an officer sale. On 10/14/2025, the company’s President sold 4,132 shares of Common Stock at $40 per share, coded “S.” The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on May 14, 2025. Following the sale, the officer beneficially owns 110,221 shares directly.
Brad Williams, President of Cadre Holdings, Inc. (ticker: CDRE), reported a sale of 4,132 shares of the company's common stock on 09/23/2025 at a price of $37 per share. Following the reported transaction, the reporting person beneficially owned 114,353 shares. The Form 4 states the sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025, and the filing was signed on September 25, 2025.
Cadre Holdings, Inc. (CDRE) filed a Form 144 reporting a proposed Rule 144 sale of common stock. The filing states a broker (UBS Financial Services, Inc., New York) is named to sell 4,132 shares with an aggregate market value of $152,884, representing a very small fraction of the issuer's reported 40,663,844 outstanding shares. The securities were acquired as restricted stock units (RSUs) on 03/09/2024 and 03/13/2024 and the filer reports no sales in the prior three months. The notice includes the standard attestation regarding material nonpublic information and Rule 10b5-1 plan language.
Cadre Holdings' Schedule 13G/A shows that Warren B. Kanders beneficially owns 11,823,511 shares of common stock, representing 28.9% of the class. The total includes 10,216,192 shares held by Kanders SAF, LLC (reported as 25%), 1,305,650 shares in a Roth IRA, 45,584 shares held personally, and 232,635 shares underlying options that are exercisable or exercisable within 60 days and therefore counted. The filing also discloses excluded awards: 229,797 options not currently exercisable and 2,071,481 restricted stock awards not vested or vesting within 60 days. Mr. Kanders is shown with sole voting and dispositive power over 11,800,061 shares and shared voting/dispositive power over 23,450 shares.
Cadre Holdings, Inc. (CDRE) Form 4 filing: CEO, Chairman and 10% owner Warren B. Kanders reported the sale of 25,000 common shares on 06/23/2025. The transaction, coded “S”, was executed at a weighted-average price of $32.78 per share through the insider-controlled entity Kanders SAF, LLC.
Following the disposition, Kanders’ reported beneficial ownership stands at 10,216,192 shares indirectly via Kanders SAF, LLC, 45,584 shares held directly, 1,305,650 shares held in his Roth IRA, and 23,450 shares held in his spouse’s Roth IRA, for an aggregate of approximately 11.59 million shares. The sale thus represents roughly 0.22 % of his total reported holdings, leaving his ownership well above the 10 % threshold.
No derivative securities were reported, and the footnotes confirm that the reported price is weighted across multiple trades ranging $32.67-$32.96. Kanders remains the sole manager of Kanders SAF, LLC and disclaims beneficial ownership beyond his pecuniary interest.
Key takeaway: The filing shows a modest insider sale in dollar terms (~$0.8 million) relative to Kanders’ large strategic stake, with no indication of broader changes in ownership structure or corporate strategy.
Cadre Holdings (CDRE) – Form 4 filed 06/23/2025. CEO, Chairman and 10% owner Warren B. Kanders disclosed two open-market sales executed through his controlled entity, Kanders SAF, LLC.
- 06/18/2025: 50,000 common shares sold at a weighted-average price of $33.95.
- 06/20/2025: 50,000 common shares sold at a weighted-average price of $33.01.
The combined 100,000-share disposal generated roughly $3.3 million in gross proceeds. Following the transactions, Kanders SAF’s holding declined to 10,241,192 shares. Additional positions remain unchanged: 45,584 shares held directly, 1,305,650 in Warren B. Kanders’ Roth IRA, and 23,450 in his spouse’s Roth IRA.
No derivative activity was reported, and the filing does not indicate the sales were made under a Rule 10b5-1 plan. While the sale size is modest relative to Kanders’ total ownership, it represents the first reported share reduction in 2025 and may be monitored by investors for sentiment signals.
FAQ
What is the current stock price of Cadre Hldgs (CDRE)?
What is the market cap of Cadre Hldgs (CDRE)?
